South Texas Alzheimer's Disease Center Research and Education Core
南德克萨斯阿尔茨海默病中心研究和教育核心
基本信息
- 批准号:10270733
- 负责人:
- 金额:$ 23.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmyloidAstrocytesAwardBasic ScienceBehavioralBig DataBiological MarkersBiologyBiometryBloodBlood PressureBlood VesselsCapsicumCaregiver BurdenCaringCertificationClinicalClinical TrialsCongressesDataDementiaDevelopmentDisciplineDoctor of PhilosophyDoctor&aposs DegreeEducationEnvironmentEpidemiologyEpigenetic ProcessFaceFacultyFosteringFundingGeneticGoalsGrantGrowthHealthHealth Knowledge, Attitudes, PracticeHealth ProfessionalHispanicsHourImageInflammationInstructionLaboratoriesLearningLengthMachine LearningMagnetic Resonance ImagingMalignant NeoplasmsMentorsMetabolicMethodsMexican AmericansMicrogliaMilitary PersonnelMindMinorityMinority AccessNeurodegenerative DisordersNeurosciencesPathway interactionsPatternPersonsPlant RootsPopulationPopulation SciencesPopulation StudyPopulations at RiskPositron-Emission TomographyPreventionPrevention strategyProgram EffectivenessProtein IsoformsProteomicsRaceResearchResearch PersonnelResearch SupportRiskScienceScientistShockSocial SciencesSouth TexasSystems BiologyTabletsTechnologyTimeTrainingTranslationsUnderrepresented MinorityUnited States National Institutes of HealthVocational GuidanceWomananalytical methodaphasia rehabilitationbasecareercohortcommunity centercommunity engagementconnectomecostdata sharingdementia caredigitaleducation researchexperienceflexibilityhealth disparityhealthy lifestyleimprovedinsightlifestyle interventionmetabolomicsminority investigatormixed dementianeurocognitive testneuroregulationnew technologypatient populationpeerperson centeredpre-clinicalprecision medicineprogramspublic health interventionradioligandrecruitresiliencerisk stratificationsenior facultysocialtau Proteinstreatment strategy
项目摘要
The cost of dementia care in the US will be $1 Trillion by 2050. Moreover, this burden will be highest among
minorities, a group that is itself diverse. The Hispanic/Latino population of South Texas, comprised of persons
of Mexican American ancestry, is the nation’s fastest growing minority but is woefully under-represented in
ADRD research. Reaching and studying this population requires a culturally attuned, highly skilled cohort of
researchers and clinicians who recognize that dementia in this group is likely to have different genetic, social,
environmental and behavioral risk and resilience factors, heterogenous biology (e.g. greater vascular/metabolic
contributions) and care needs (e.g. higher caregiver burden). Expanding the research and clinical workforce
will necessitate attracting the brightest minds from related disciplines to dementia research. It also requires
being able to recruit, retain and support the career growth of fellows and faculty, with diverse race-, ethnic-,
social backgrounds, providing additional, targeted support for promising women and under-represented
minority researchers who may lack access to mentoring networks or key information.
The Research Education Core (REC) of the STAC, will be a leader in achieving this and sharing our
insights nationally. The REC is led by Profs. Cavazos, Maestre and Mahaney who each have deep roots in the
Hispanic community and South Texas, a superb track record of successful NIH and VA funding and of
academic mentoring especially minority (Hispanic) MD and MD/PhD researchers. They will be supported by
other outstanding senior faculty and an impressive cadre of emerging mentors. The REC will offer a 12 credit-
hour Graduate Certificate on Dementia and developmental grants to introduce a wide range of health
professionals to issues in dementia research. The flagship program of our REC will be to identify and support
9 outstanding faculty candidates, through 2- year K type awards that include a mentored research
experience, strong career guidance and culminate in external research funding. Our goal is to grow thought
leaders in ADRD research. We propose these Specific Aims: 1) Grow a cadre of researchers representing
and/or focusing on all aspects of Hispanic health 2) Broad training across clinical, laboratory, imaging,
computational, omics, epidemiology, biostatistics, social science and community engagement domains 3)
Emphasis on training clinician, basic and population science researchers to become independent investigators
skilled in T1 and T2 translation, team science and mentoring 4) Emphasis on instruction in cutting-edge
technologies and analysis methods with a focus on precision medicine approaches and optimal, community
and person centered prevention and care. We will carefully evaluate program effectiveness and adjust
accordingly. UTHSA and UTRGV are national leaders in Hispanic education and recruitment and the STAC
REC will leverage the rich local training environment (AD-RCMAR, CTSI, Pepper, Nathan Shock, GRECC,
military research/researchers) to grow superb ADRD researchers.
到2050年,美国痴呆症护理的成本将达到1万亿美元。此外,这一负担将是最高的,
少数民族,一个本身就具有多样性的群体。德克萨斯州南部的西班牙裔/拉丁裔人口,包括
墨西哥裔美国人的血统,是全国增长最快的少数民族,但可悲的是,
ADRD研究。接触和研究这一人群需要一个文化上协调一致的,高技能的群体,
研究人员和临床医生认识到,这一群体中的痴呆症可能具有不同的遗传,社会,
环境和行为风险和弹性因素,异质生物学(例如,更大的血管/代谢
贡献)和护理需求(例如,更高的照顾者负担)。扩大研究和临床劳动力
将有必要吸引相关学科的最聪明的头脑来研究痴呆症。它还要求
能够招聘,留住和支持研究员和教师的职业发展,与不同的种族,民族,
社会背景,为有前途的妇女和任职人数不足的妇女提供额外的有针对性的支助
少数族裔研究人员可能无法获得指导网络或关键信息。
STAC的研究教育核心(REC)将成为实现这一目标的领导者,并分享我们的
全国性的见解。REC由教授领导。卡瓦佐斯,梅斯特和马哈尼谁都有很深的根源,
西班牙裔社区和南德克萨斯州,成功的NIH和VA资助以及
学术指导,特别是少数民族(西班牙裔)MD和MD/PhD研究人员。他们将得到支持,
其他优秀的高级教师和一个令人印象深刻的干部新兴导师。REC将提供12个学分-
小时的痴呆症和发展赠款金研究生证书,以介绍广泛的健康
专业人士在痴呆症研究的问题。我们REC的旗舰计划将是识别和支持
9名优秀教师候选人,通过2年K型奖,其中包括指导研究
经验,强大的职业指导,并最终在外部研究资金。我们的目标是让思想
ADRD研究的领导者。我们提出这些具体目标:1)培养一批研究人员,
和/或专注于西班牙裔健康的所有方面2)在临床,实验室,成像,
计算、组学、流行病学、生物统计学、社会科学和社区参与领域3)
强调培养临床医生、基础和人口科学研究人员成为独立的研究者
熟练的T1和T2翻译,团队科学和指导4)强调尖端的教学
技术和分析方法,重点是精确医学方法和最佳的,
以人为本的预防和护理。我们将仔细评估计划的有效性,
相应地UTHSA和UTRGV是西班牙裔教育和招聘以及STAC的国家领导者
REC将利用丰富的本地培训环境(AD-RCMAR、CTSI、Pepper、Nathan Shock、GRECC,
军事研究/研究人员)培养优秀的ADRD研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose E Cavazos其他文献
Jose E Cavazos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose E Cavazos', 18)}}的其他基金
South Texas Medical Scientist Training Program (STX-MSTP)
南德克萨斯医学科学家培训计划 (STX-MSTP)
- 批准号:
10411758 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
South Texas Alzheimer’s and Neurodegenerative Disorders Training Program
南德克萨斯阿尔茨海默病和神经退行性疾病培训计划
- 批准号:
10713507 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
South Texas Alzheimer's Disease Center Research and Education Core
南德克萨斯阿尔茨海默病中心研究和教育核心
- 批准号:
10472677 - 财政年份:2021
- 资助金额:
$ 23.98万 - 项目类别:
South Texas Alzheimer's Disease Center Research and Education Core
南德克萨斯阿尔茨海默病中心研究和教育核心
- 批准号:
10662358 - 财政年份:2021
- 资助金额:
$ 23.98万 - 项目类别:
South Texas Medical Scientist Training Program (STX-MSTP)
南德克萨斯医学科学家培训计划 (STX-MSTP)
- 批准号:
10409684 - 财政年份:2018
- 资助金额:
$ 23.98万 - 项目类别:
South Texas Medical Scientist Training Program (STX-MSTP)
南德克萨斯医学科学家培训计划 (STX-MSTP)
- 批准号:
10158492 - 财政年份:2018
- 资助金额:
$ 23.98万 - 项目类别:
South Texas Medical Scientist Training Program (STX-MSTP)
南德克萨斯医学科学家培训计划 (STX-MSTP)
- 批准号:
9924556 - 财政年份:2018
- 资助金额:
$ 23.98万 - 项目类别:
South Texas Medical Scientist Training Program (STX-MSTP)
南德克萨斯医学科学家培训计划 (STX-MSTP)
- 批准号:
10377635 - 财政年份:2018
- 资助金额:
$ 23.98万 - 项目类别:
NEUROPHYSIOLOGICAL STUDY OF CA1 SYNAPTIC REORGANIZATION
CA1 突触重组的神经生理学研究
- 批准号:
6187722 - 财政年份:1998
- 资助金额:
$ 23.98万 - 项目类别:
Neurophysiological Study of CA1 Synaptic Reorganization
CA1突触重组的神经生理学研究
- 批准号:
6438879 - 财政年份:1998
- 资助金额:
$ 23.98万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 23.98万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 23.98万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 23.98万 - 项目类别: